Penumbra, Inc Defined Contribution Plan, Cost
Penumbra, Inc (PEN) reported Defined Contribution Plan, Cost of $8.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-25
- Penumbra, Inc defined contribution plan, cost for fiscal 2025 was $8.10M, a 17.39% increase from fiscal 2024.
- Penumbra, Inc defined contribution plan, cost for fiscal 2024 was $6.90M, a 4.55% increase from fiscal 2023.
- Penumbra, Inc defined contribution plan, cost for fiscal 2023 was $6.60M, a 1.49% decline from fiscal 2022.
- Penumbra, Inc defined contribution plan, cost for fiscal 2022 was $6.70M, a 19.64% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $8.10M 10-K · filed 2026-02-25 |
| 2024-12-31 | $6.90M 10-K · filed 2026-02-25 |
| 2023-12-31 | $6.60M 10-K · filed 2026-02-25 |
| 2022-12-31 | $6.70M 10-K · filed 2025-02-18 |
| 2021-12-31 | $5.60M 10-K · filed 2024-02-22 |
| 2020-12-31 | $4.50M 10-K · filed 2023-02-23 |
| 2019-12-31 | $3.20M 10-K · filed 2022-02-22 |
| 2018-12-31 | $1.60M 10-K · filed 2021-02-23 |
| 2017-12-31 | $1.10M 10-K · filed 2020-02-26 |
| 2016-12-31 | $800.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $300.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |